BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 45 filers reported holding BOLT BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $327 | -47.2% | 314,189 | -35.1% | 0.00% | 0.0% |
| Q2 2023 | $619 | -2.5% | 483,939 | +6.0% | 0.00% | 0.0% |
| Q1 2023 | $635 | +10.6% | 456,739 | +3.4% | 0.00% | 0.0% |
| Q4 2022 | $574 | -99.9% | 441,539 | +12.1% | 0.00% | 0.0% |
| Q3 2022 | $583,000 | -47.0% | 393,858 | -26.9% | 0.00% | 0.0% |
| Q2 2022 | $1,099,000 | +38.2% | 538,573 | +85.7% | 0.00% | 0.0% |
| Q1 2022 | $795,000 | +82.3% | 290,100 | +226.3% | 0.00% | 0.0% |
| Q4 2021 | $436,000 | -56.5% | 88,900 | +12.1% | 0.00% | 0.0% |
| Q3 2021 | $1,003,000 | +7.3% | 79,300 | +31.1% | 0.00% | 0.0% |
| Q2 2021 | $935,000 | – | 60,470 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $23,927,000 | 8.46% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $14,762,000 | 4.72% |
| Novo Holdings A/S | 4,503,991 | $56,975,000 | 2.95% |
| Vivo Capital, LLC | 3,871,291 | $48,972,000 | 2.20% |
| Sofinnova Investments, Inc. | 2,754,437 | $34,844,000 | 2.06% |
| Samsara BioCapital, LLC | 737,459 | $9,329,000 | 1.46% |
| Ally Bridge Group (NY) LLC | 257,267 | $3,254,000 | 0.96% |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $9,102,000 | 0.68% |
| Rock Springs Capital Management LP | 1,649,248 | $20,863,000 | 0.44% |
| RA Capital Management | 2,378,325 | $30,086,000 | 0.42% |